FidoCure®

FidoCure® is the leader in Precision Medicine for Canine Oncology.

Palo Alto, United States · Founded 2016

Employees
11–50
Founded
2016
Business Model
B2B
Last Round
Series AOct 2020
Rounds
2

About

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

Summary

FidoCure® is a Healthcare company based in Palo Alto, United States, founded in 2016. Its most recent funding was a Series A round in Oct 2020. Investors include Andreessen Horowitz, Polaris Partners and Lerer Hippeau.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2020

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

FidoCure® on Indexed.vc
<a href="https://indexed.vc/companies/fidocure"><img src="https://indexed.vc/api/badge/company/fidocure" alt="FidoCure® on Indexed.vc" width="260" height="76" /></a>